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Moleculardockingsimulationsarenowfastdevelopingareaofresearch.Inthisworkwe
describe an effective procedure of preparation of the receptor–ligand complexes. The
amino-acid residues involved in ligand binding were identified and described.
In recent years, conformationally constrained
analogs of well-known bioactive peptides have ac-
quired a growing importance in the effort to es-
tablish the relationships between the three dimen-
sional structure and biological activity. Since the
existing agonists and antagonists are still far
from perfect, such knowledge could be of great
help in the design of new, highly active ligands
with improved selectivity. In pharmacological
tests regarding the relation between structure of a
specific bioligand and its bioactivity an important
part take agonists and antagonists both peptide
and nonpeptide, of human hormones: vasopressin
and oxytocin (OT) — the subjects of our interest.
In this work we have considered two potent selec-
tive V1a receptor (V1aR) antagonists: [Mca1,
Tyr(Me)2]AVP and DesGly9-[Mca1]AVP, where
Mca stands for ,-cyclopentamethyleno--mer-
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METHODS
Starting models of new ligands and receptors
were constructed using homology modeling. This
part of our work involved usage of the available
amino-acid sequences [1] in conjunction with a
search within crystallographic database CSDS [2].
Three-dimensional (3D) models of our receptors:
V1aR, V2R and oxytocin receptor, were built us-
ing the human opiate- receptor model proposed
by Pogozheva and coworkers [3]. The missing 2nd
and 3rd cytosolic loops and the extracellular N-
and C-termini were built using the SYBYL [4]
suite of programs. For verification of our 3D theo-
retical model of V1a,V 2 and OT receptors (OTR)
we have calculated the root mean square (RMS)
deviation between our theoretical 3D structures
and the X-ray crystal structure of rhodopsin at 2.8
Å resolution, which was published recently [5].
The result: 2.66 Å positively verifies our com-
puter-modeled 3D structures. The next steps
were: 1. preparation of full-atom models with
atomic charges, 2. their relaxation and mini-
mization (stand-alone and in the complexes with
V1aR, V2R and OTR). All non-standard amino-
acid residues included in both docked ligands
were parameterized in accordance with the rec-
ommendations in the AMBER 5.0 [6] manual.
Atomic net charges were optimized by fitting to
the ab initio molecular electrostatic potentials (us-
ing the 6-31G* basis set in the GAMESS [7] molec-
ular program package). Minimization of these
models was done in AMBER 5.0 force field using
constraints for transmembrane domains in V1aR,
V2R and OTR models based on the opiate recep-
tor models proposed by Pogozheva et al. [3]. The
starting models of ligand-receptor complexes
were prepared using the AutoDock 3.0 [8] pro-
gram. These computer-docked and minimized
models were subsequently used as the starting
point in the discussion of the properties of
newly-designed ligands and for the characteriza-
tion of the binding sites of our receptors. Final
complexes were selected based on the criterion of
the internal ligand energy of the minimized recep-
tor-ligand complexes. The amino-acid residues in-
volved in ligand binding were identified and de-
scribed. The docking procedure involved the
AutoDock 3.0 program and its new and promising
hybrid search technique that implements an adap-
tive global optimizer with local search. The global
search method is an implementation of a modified
genetic algorithm, with 2-point crossover and ran-
dom mutation. The local search method is based
on the optimization algorithm of Solis & Wets [9],
which has the advantage that it does not require
gradient information in order to proceed — as was
the case in previous versions of AutoDock. It also
uses fixed variances for the determination of the
probabilistic way of a change of a particular state
variable, like the x-translation. These variances
are either doubled or halved during the search, de-
pending on the number of consecutive successful
or failed moves. Success is a drop in energy. Re-
ceptor-ligand complexes were relaxed and mini-
mized by the consecutive use of the minimization
and constrained simulated annealing (CSA) pro-
tocols in vacuo (in accordance to the AMBER 5.0
manual [6]) with all but the trans-
membrane-domain C atoms free to move. This
was done in the AMBER 5.0 force field. Sample
complexes of docked ligands are presented in
Fig. 1.
RESULTS AND DISCUSSION
For CSA refinement only those complexes were
retained whose receptor-ligand interaction energy
was about 1000 kcal/mole or less above the abso-
lute minimum. The AutoDock force field used in
the docking procedure is very limited in its func-
tionality — it uses electrostatic interactions and
van der Waals potential. This 1000 kcal/
mole-criterion eliminated all complexes which
were not properly minimized by AMBER. For effi-
cient relaxation of the remaining part of com-
plexes we used CSA with heating the environment
up to 1200 K (1 ps), keeping this temperature con-
stant (2 ps) and re-cooling to low temperatures
(12 ps of CSA) — as shown in Fig. 2. Having this
132 R. Œlusarz and others 2001done we have selected, based on the energetic cri-
terion, 5–7 complexes of [Mca1, Tyr(Me)2]- AVP
and DesGly9-[Mca1]AVP in each of the V1aR, V2R
and OTR receptors. Their final energies are pre-
sented in Table 1. Receptor amino-acid residues
responsible for binding new ligands were identi-
fied on the basis of the distance criterion. The res-
idues whose any atom is not further than 4.5 Å
away from all accepted conformations of our lig-
ands are shown in Table 2 and arranged so that
the more often a particular residue is involved in
binding the ligand the higher is the position it oc-
cupies in the table.
Not in line with our expectations both ligands
were docked relatively shallow in the binding site
of the V1a receptor — close to the extracellular
loops. Their minimization and relaxation did not
radically change their position, which suggests
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A
Figure 1. Stereoview of ligand Mca
1,Tyr(Me)
2]AVP (panel A) and DesGly
9-[Mca
1]AVP (panel B) docked in hu-
man V2 receptor.
Theamino-acidresiduesresponsibleforligandbindingarecoloredaccordingtotheirchemicalproperties.Colorsofpolar
amino-acid residues are brighter than non-polar. We used standard RasMol (Sayle, R., RasMol V2.6, Molecular Visualisa-
tion Program, Glaxo Wellcome Research and Development, Stevenage, Hertfordshire, U.K.) color coding of all receptor
amino-acid residues.
Bthe optimal docking. Ligands in complexes with
the other two receptors (V2R and OTR) were
docked in the midst of the docking nest on the
extracellular sides of the receptors. This nest, sur-
rounded by the helices TM3-TM7 is bordered with
the extracellular loops on its top and (in V1aR, V2
and OTR, respectively) with: TM2: P(107,95,95);
TM3: M(135,123,123); TM5: V(217,206,208),
T(218,207),Y(209); TM6: W(304,285,288),
F(308,289,291), F(309,290,292); and TM7:
A(334),M(311,315) on their bottom. Both our lig-
ands being rather small molecules (93 and 97 at-
oms) had the advantage of free movements within
the receptors’ pockets but their positions did not
change much even after a relatively hot (up to
1200 K) CSA, despite allowing unconstrained flex-
ibility to all TM side chains, both ligands and the
receptors’ loops. This suggests a very good imple-
mentation of the genetic algorithm in the docking
procedure even though the ligand–receptor inter-
action energies were extremely high. Slight differ-
ences between the conformations of the two lig-
ands complexed to the three receptors studied (es-
pecially between V1a and V2 receptors) show that
the CSA protocol caused good relaxation of lig-
ands and found very good minima.
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Table 1. Energies of ligand–receptor complexes [kcal/mole]
Figure 2. Changes in temperature during the con-
strained simulated annealing (CSA).
This sample drawing presents changes in temperature
duringCSAof DesGly
9-[Mca
1]AVPligandinOTreceptor.We acknowledge professor Henry I. Mosberg of
the University of Michigan, Ann Arbor, U.S.A. for
making the G Protein-Coupled Receptor tem-
plates available.
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